Tag Archives: ANDA

Dr REDDY’s gets USFDA nod to market medicine to treat tumour

PRINCETON (NEW JERSEY – US) HYDERABAD | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Hyderabad headquartered pharmaceutical company Dr Reddy’s Laboratories Ltd said of having got USFDA (US Food & Drugs Administration) nod to market medicine to treat tumour for bone-marrow and cancer and has

STRIDE PHARMA gets USFDA nod to market pain-killer medicine

BANGALORE | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered pharmaceuticals company Strides Pharma Sciences Ltd said its Singapore based step-down subsidiary company Strides Pharma Global Pte. Ltd., Singapore of having got USFDA (US Food and Drugs Administration) approval to market pain-killer medicine –

ALEOR DERMA gets USFDA nod to market medicine to treat knee pain

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of its joint-venture company Aleor Dermaceuticals having got USFDA nod to market medicine to treat knee pain. In a press-release as submitted by the company to the

ALEMBIC PHARMA gets USFDA nod to sell medicine to cure Prostate Enlargement

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Alembic Pharmaceuticals Ltd said of having got nod to market medicines to treat prostate enlargement disease. In a press-release as submitted by the company to the Indian Bourses, titled – “Alembic Pharmaceuticals receives

GLENMARK PHARMA gets USFDA nod to market medicine to treat obesity

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Glenmark Pharmaceuticals Ltd said of having received USFDA (US Food and Drugs Administration) nod to market medicine to treat obesity and overweight related disorders. In a company press-release as submitted to the Indian Bourses, titled – “Glenmark

ALEMBIC PHARMA gets USFDA nod to sell tablets to treat iron levels in blood

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vaoddara headquartered pharmaceutical products manufacturing company Alembic Pharmaceuticals Ltd said of having got nod to market medicine to treat iron levels in blood, especially to treat chronic iron overload due to blood transfusions in patients of

GLENMARK PHARMA gets USFDA nod to market skin & pimple care treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Mumbai headquartered pharma company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food & Drugs Administration) to market skin & pimple care treatment. The press-release as submitted by the company to the Indian Bourses – titled, “Glenmark

USFDA issues warning, initiates official action against LUPIN’s Mandideep unit

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma major Lupin Ltd said of US FDA (Food & Drugs Administration) having issued warning letter and initiated official action against Mandideep facility of the company. The company update as submitted to the Indian Bourses read

UNICHEM LABS gets USFDA nod to market URINARY disorder treatment

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered Unichem Laboratories Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat urinary disorders. The company statement submitted to the Indian Bourses read that, Unichem Laboratories Limited is pleased to

STRIDES PHARMA acquires USFDA approved manufacturing facility in the US

BENGALURU | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Bengaluru & Mumbai headquartered Indian Pharma Major, Strides Pharma Science Ltd said of having acquired US FDA (Food & Drugs Admininstration) approved manufacturing facility at Riviera Beach (Florida) in The United State of America. The press-release as

GLENMARK gets USFDA nod to market medicine to treat BREAST-CANCER

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update filing sumitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma company Glenmark Pharmaceuticals Ltd said of having got approval from US FDA (Food & Drugs Administration) to market injections to treat breast-cancer. The press-communication submitted by the company to the Indian Bourses titled –

Cadila gets USFDA nod to market blood-pressure, heart disease treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharma major Cadila Healthcare Ltd (Dr. Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market tablets to treat blood-pressure and heart disease. The press-statement, as addressed by

Patent Infringement case filed against Sun Pharma

NEW JERSEY (US) | VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian Pharma major Sun Pharma Advanced Research Company (SPARC) Ltd said of complaint filed at one of the US District Courts at New Jersy, against the company, alleging patent

Alembic Pharma gets USFDA nod to market drug to treat cholestoral levels

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR-RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian pharma major, Alembic Pharmaceuticals Ltd said of having got nod from US FDA (Food & Drugs Administration) to market drug to treat cholesterol related disorders. The press-statement titled, “Alembic Pharmaceuticals receives USFDA Approval for

Unichem Laboratories gets USFDA nod to market pain-killer durg

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Mumbai headquartered pharma major Unichem Laboratories Ltd said of having got US FDA (US Food & Drugs Administration) nod to market pain-killer drug. The press-statement submitted by the company to the Indian Bourses read that, Unichem Laboratories Limited is pleased

Alembic Pharma gets USFDA nod to market eye-disease treatment solution

VADODARA (BARODA) | MUMBAI | AHMEDABAD-GANDHINAGAR-RAJKOT – In a press release submitted to the Indian Stock Exchanges, Vadodara (Baroda) Gujarat headquarted Indian Pharma company Alembic Pharmaceuticals Ltd said of having got US FDA (Food & Drugs Administration) nod to market ophthalmic (eye-disease treatment) solution. The press release submitted by the company read that, Alembic Pharmaceuticals receives

Do NOT follow this link or you will be banned from the site!